The Pituitary World News Podcast

S5E14: A fascinating chat between a patient and her doctor

Don't miss today's podcasts. Sometimes it is through these genuine, unscripted chats that we get insight into what it is like to deal with chronic pituitary disease, in this case, acromegaly. This podcast is no exception. In it, Dr. Blevins and his patient Monica talk about it and deliver a fascinating perspective

S5E13: Silent Pituitary Adenomas

Our podcast today is on silent pituitary adenomas.  This is a fascinating look into these tumors that are thought not to secrete hormones.  In the podcast Dr. Blevins discusses the complexities and challenges when dealing with these specific adenomas. The podcast also mentions a recent paper on the subject published in the Journal of Clinical Endocrinology and Metabolism.  Click here to read more about the abstract.

S5E12: Pegvisomant, glucose metabolism, and acromegaly

In this podcasts, we discuss an important recent meta-analysis study from the University of Rome on the relationship between pegvisomant, a drug used for the treatment of acromegaly, and glucose metabolism. Dr. Blevins also dives into a fascinating discussion about meta-analysis studies, their advantages, and limitations and, importantly, the need to be very cautious when reading the results. Like in any search, there is excellent information out there, but there is also copious amounts of trash.

S5E11: Why do adenomas recur?

Today's podcast is about silent Corticotropic adenomas and the recurrence rate of these tumors vs. all pituitary adenomas.  Dr. Blevins weighs into a recent paper as well as current research to discuss why adenomas recur and importantly, why long term follow-up is essential and must be continued.

S5E10: An informal chat about today's health insurance's trials and tribulations

Frustrations with the health insurance industry seem to be steadily increasing for patients and physicians alike as politicians use patients as pawns in a sad, ridiculous game without any apparent care to people's health and well being.  This podcast offers a glimpse into physicians and patients growing frustrations with the system.

S5E9: A review of drugs for tumors that produce ACTH

In this podcast, Dr. Blevins reviews a study conducted at the Ludwig Maximilian University of Munich, Germany on pituitary tumor therapeutics and the treatment for tumors that produce ACTH and cause Cushing's.  Dr. Blevins reviews study findings and discusses the things that can be done against a tumor other than surgery and radiotherapy.  These studies may have an essential role in the management of Cushing's disease in the future.

S5E8: Oxytocin and hypopituitarism

In this podcast, Dr. Blevins dives into a very interesting paper recently published in the Journal of Pituitary, April 2019.  The paper focuses on a study about oxytocin and hypopituitarism relating to emotional responses and reactions as well as other neuropsychiatric problems

S5E7: The incidence of Cushing's

In this podcast, we discuss the latest data on the incidence of Cushing's disease worldwide based on a recent Swedish study on the subject, and the importance of disease awareness in early diagnosis.

S5E6: Adult Growth Hormone Deficiency: a talk with Dr. Kevin Yuen

Pituitary World News co-founder Dr. Lewis Blevins talks to Dr. Kevin Yuen, a leading neuroendocrinologist and medical director of the Barrow Pituitary Center and Barrow Neuroendocrinology Clinic in Phoenix, Arizona.  Dr. Yuen was instrumental in the development of studies of a new molecule used in diagnostics and testing of AGH deficiency. The discussion focuses on new development in GH stimulation test and medical decision making.  This lively talk also touches on new guidelines for the treatment of Adult Growth Hormone Deficiency and the dangers of GH use in aging and sports.

S5E5: Radiotherapy induce​d hypopituitarism

In this highly informational podcats, Dr. Blevins discussed his experiences with patients that receive radiotherapy and develop hypopituitarism at a later date.  On average, two-thirds of patients who undergo this procedure develop one or more partial or complete deficiencies of anterior pituitary hormones.  Learn more about the risks, current diagnosis, and treatment trends.